In Almaty, the availability of drugs in 375 pharmacies is monitored for 22 main items included in the COVID treatment protocol
This was announced at a briefing at the site of the regional communications service by the coordinator for drug provision of the city of Almaty, chairman of the board of Almaty Finance Timur Khairov.
In particular, such wholesale companies as "Emiti" and "Zerde" have already received about 11 thousand packages of Cardiomagnil in accordance with the new maximum prices, and are supplying them to pharmacies in Almaty for retail sale. The "Emiti" company shipped the drug to 77 legal entities, "Zerde" - 43, engaged in retail sales both through 1 pharmacy and through its own network of pharmacies.
The Stabilization Fund of Anti-COVID Medicines was created by the decision of the Akimat of the city of Almaty in July 2020. About 5 billion tenge was allocated for its formation through the issuance of concessional loans under a revolving scheme.
Pharmaceutical companies purchased more than 47 million units of medicines and medical devices in 68 items. About 27 million units were delivered to pharmacies in the city of Almaty, and there are about 20 million units of drugs in warehouses, of which 8 million are the irreducible balance.
District akimats of the city systematically monitor the availability of medicines in 375 pharmacies of the city, for 22 main items included in the COVID-19 treatment protocol.
Earlier, it was reported that new price caps were approved for Cardiomagnil 150mg No. 100 and Cardiomagnil 75 mg No. 100 for wholesale in the amount of 1,166 (one thousand one hundred sixty-six) tenge and 884 (eight hundred eighty-four) tenge, respectively, which caused temporary interruptions with supplies of the drug Cardiomagnil. However, there were other drugs in the city's pharmacies with the same international non-proprietary name "Acetylsalicylic acid". These are drugs such as Thrombopol NEO, As thrombin, Thrombo ACC and others.
The supplier of Cardiomagnet to the Republic of Kazakhstan is a subsidiary of the manufacturer of Cardiomagnil - LLP "Nizhpharm".
“We have received an official confirmation from the company, that today they have imported about 1 million packages of this drug, currently available, and their readiness to supply it in full compliance with the maximum wholesale prices approved in the Republic of Kazakhstan to wholesale suppliers throughout Kazakhstan. The company has already shipped to suppliers for subsequent delivery to pharmacies of the Republic, including pharmacies in the city of Almaty, ”said Timur Khairov.